Minerva Neurosciences, Inc. (NERV): Nasdaq/NYSE listing notice — Minerva Neurosciences receives Nasdaq delisting notice for low market value

Minerva Neurosciences, Inc.

MVLS below $35M minimum for 31 consecutive business days as of April 10, 2024.
Grace period of 180 days until October 7, 2024 to regain compliance.
To regain compliance, MVLS must be at least $35M for 10 consecutive business days.
Failure to comply may result in delisting from the Nasdaq Capital Market.

item 3.01

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.95

Minerva Neurosciences, Inc. received a nasdaq deficiency notice notice regarding market value (rules 5550(b)(2)).

Exchange: nasdaq
Notice: deficiency notice
Deficiency: market value
Rules: 5550(b)(2)

Exact text from the filing

April 10, 2024, Minerva Neurosciences, Inc. (the “Company”) received notice (the “Notice”) from The Nasdaq Stock Market LLC (“Nasdaq”) that the Company was not in compliance with Nasdaq’s Listing Rule 5550(b)(2), as the market value of listed securities (the “MVLS requirement”) for the Company’s common stock had been below the minimum MVLS requirement of $35,000,000 for the last 31 consecutive business days. The notification of noncompliance indicated that the Company would be provided 180 calendar days in which to regain compliance with the MVLS requirement. The Notice provides the Company wi

View on SEC.gov

93 listing & compliance notices filed in the last 30 days. Browse all listing & compliance notices →

Minerva Neurosciences, Inc. filing history →

Source: SEC EDGAR

accession 0001193125-24-094620

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.